Analysis of Cdc2 and cyclin D1 expression in breast cancer by immunoblotting

Tomohiko Ohta*, Mamoru Fukuda, Kei Arima, Hisanori Kawamoto, Rintaro Hashizume, Toshihiro Arimura, Susumu Yamaguchi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Cyclins and cyclin-dependent kinases may reflect the status of cell proliferation in cancer tissues. The authors sought to determine whether cdc2 and cyclin D1 are expressed in breast cancer and are useful as prognostic factors. Accumulation of cdc2 and cyclin D1 proteins was examined in 88 cases of breast cancer using immunoblotting techniques and correlations with clinicopathological factors and prognoses were investigated. Cdc2 and cyclin D1 proteins were observed in 27.3% and 75.0% of breast cancers studied, respectively. The incidence of lymph node metastasis was significantly high in cdc2/cyclin D1-double positive group and low in double negative group. On the other hand, the incidence of estrogen receptor (ER) negative cases was significantly higher in the cdc2-positive/cyclin D1-negative group. Relapsefree survival times of cdc2-positive cases were significantly shorter than those of cdc2-negative cases. The relapse-free survival times of cyclin D1-positive cases also tended to be poorer than those of cyclin D1-negative cases. Multivariate analyses revealed cdc2 as the second most significant of the prognostic variables, following lymph node status. The three-year relapse-free survival rate of cdc2/cyclin D1-double positive cases was 58.9%, whereas that of cdc2/cyclin D1-double negative cases was 100%. Cdc2 and cyclin D1 represent the status of cell proliferation in breast cancer, and may be useful in breast cancer assessment.

Original languageEnglish (US)
Pages (from-to)17-24
Number of pages8
JournalBreast Cancer
Issue number1
StatePublished - Mar 1997


  • Breast cancer
  • Cdc2
  • Cyclin D1
  • Prognosis

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology (medical)


Dive into the research topics of 'Analysis of Cdc2 and cyclin D1 expression in breast cancer by immunoblotting'. Together they form a unique fingerprint.

Cite this